We currently have no Breaking News on this stock.
There are no StockTalks on this stock yet.
ALSE vs. ETF Alternatives
Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). Our lead product candidate is Altropane, a proprietary molecular imaging agent used to diagnose Parkinson's disease and dementia. Altropane is... More
Other News & PR